$179 Billion is the total value of Baillie Gifford's 1100 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QS | QuantumScape Corp | $40,869,000 | -47.0% | 913,279 | 0.0% | 0.02% | -46.5% | |
| STRO | Sutro Biopharma | $38,593,000 | +4.8% | 1,695,654 | 0.0% | 0.02% | +10.0% | |
| UBX | Unity Biotechnology Inc | $22,818,000 | +14.5% | 3,803,014 | 0.0% | 0.01% | +18.2% | |
| NBTX | Nanobiotix ADR | $21,028,000 | -9.0% | 1,400,000 | 0.0% | 0.01% | -7.7% | |
| ALGN | Align Technology Inc | $15,892,000 | +1.3% | 29,346 | 0.0% | 0.01% | 0.0% | |
| V | Visa Inc-Class A Shares | $15,316,000 | -3.2% | 72,337 | 0.0% | 0.01% | 0.0% | |
| COO | Cooper Cos Inc/The | $13,712,000 | +5.7% | 35,700 | 0.0% | 0.01% | +14.3% | |
| VVR | Invesco Senior Income Trust | $13,422,000 | +5.5% | 3,195,695 | 0.0% | 0.01% | +14.3% | |
| SHW | Sherwin-Williams Co | $12,274,000 | +0.4% | 16,631 | 0.0% | 0.01% | 0.0% | |
| VRSK | Verisk Analytics | $10,163,000 | -14.9% | 57,521 | 0.0% | 0.01% | -14.3% | |
| BGT | BlackRock Floating Rate Income | $9,811,000 | +6.1% | 784,230 | 0.0% | 0.01% | 0.0% | |
| SOHU | Sohu.com | $3,146,000 | -1.4% | 200,140 | 0.0% | 0.00% | 0.0% | |
| SMMT | Summit Therapeutics New Listing | $2,185,000 | +24.9% | 372,261 | 0.0% | 0.00% | 0.0% | |
| UXIN | Uxin ADRads | $2,078,000 | +34.1% | 1,776,100 | 0.0% | 0.00% | 0.0% | |
| ACET | Adicet Bio Inc | $2,375,000 | -6.9% | 181,626 | 0.0% | 0.00% | 0.0% | |
| APRN | Blue Apron Holdings Inccl a | $937,000 | +12.9% | 148,506 | 0.0% | 0.00% | – | |
| NLY | Annaly Capital Man. | $64,000 | +1.6% | 7,446 | 0.0% | 0.00% | – | |
| ATEX | Anterix | $8,000 | +33.3% | 162 | 0.0% | 0.00% | – | |
| AAOI | Applied Optoelectronics | $2,000 | 0.0% | 260 | 0.0% | 0.00% | – | |
| AGX | Argan | $5,000 | 0.0% | 103 | 0.0% | 0.00% | – | |
| ATRI | Atrion | $6,000 | 0.0% | 9 | 0.0% | 0.00% | – | |
| BLK | Blackrock Inc | $16,000 | +6.7% | 21 | 0.0% | 0.00% | – | |
| HD | Home Depot | $19,000 | +18.8% | 61 | 0.0% | 0.00% | – | |
| FIXX | Homology Medicines | $5,000 | 0.0% | 481 | 0.0% | 0.00% | – | |
| MBT | Mobile Telesystems ADRsponsored adr | $248,000 | -6.8% | 29,700 | 0.0% | 0.00% | – | |
| MOD | Modine Manufacturing Co | $8,000 | +14.3% | 558 | 0.0% | 0.00% | – | |
| PTCT | Ptc Therapeutics Inc | $12,000 | -20.0% | 246 | 0.0% | 0.00% | – | |
| PBYI | Puma Biotechnology | $2,000 | -33.3% | 252 | 0.0% | 0.00% | – | |
| WPM | Wheaton Precious Metals | $312,000 | -8.5% | 8,165 | 0.0% | 0.00% | – | |
| ZYXI | Zynex | $7,000 | +16.7% | 437 | 0.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-06
About Baillie Gifford
Baillie Gifford is a well-known investment management firm that has been in operation for over a century. The company was founded in 1908 and is headquartered in Edinburgh, Scotland. Baillie Gifford has a reputation for being a long-term investor, with a focus on growth-oriented companies. The firm manages a range of investment strategies, including equities, fixed income, and multi-asset portfolios.
Baillie Gifford has a team of experienced investment professionals, including its CEO, Andrew Telfer, and its Chief Investment Officer, Charles Plowden. The firm's investment philosophy is based on the belief that long-term investing is the best way to achieve superior returns. Baillie Gifford's investment process involves in-depth research and analysis of companies, with a focus on identifying those with strong growth potential.
One of the key strengths of Baillie Gifford is its focus on innovation. The firm has a history of investing in companies that are disrupting traditional industries, such as Tesla and Amazon. Baillie Gifford also has a strong track record of investing in emerging markets, such as China and India.
Overall, Baillie Gifford is a respected investment management firm with a long history of delivering strong returns for its clients. The firm's focus on long-term investing and innovation has helped it to stand out in a crowded market, and its experienced team of investment professionals is well-equipped to navigate the challenges of today's investment landscape.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Amazon.Com | 42 | Q3 2023 | 10.0% |
| Tesla Motors | 42 | Q3 2023 | 10.7% |
| Illumina | 42 | Q3 2023 | 6.6% |
| Baidu.com Sponsored ADR | 42 | Q3 2023 | 11.6% |
| Meta Platforms Inc | 42 | Q3 2023 | 5.0% |
| MercadoLibre | 42 | Q3 2023 | 7.3% |
| Intuitive Surgical | 42 | Q3 2023 | 3.5% |
| Moody's Corp | 42 | Q3 2023 | 1.4% |
| MasterCard Inc-Class A | 42 | Q3 2023 | 1.9% |
| Workday Inc | 42 | Q3 2023 | 1.4% |
View Baillie Gifford's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Oddity Tech Ltd | September 07, 2023 | 4,914,661 | 10.9% |
| Roblox Corp | September 07, 2023 | 28,106,215 | 5.0% |
| SiteOne Landscape Supply, Inc. | August 03, 2023 | 2,234,985 | 5.0% |
| UPWORK, INC | August 03, 2023 | 6,565,230 | 4.9% |
| CHINOOK THERAPEUTICS, INC. | August 01, 2023 | 844,684 | 2.0% |
| MELI Kaszek Pioneer CorpSold out | July 05, 2023 | 0 | 0.0% |
| Abcam plc | June 08, 2023 | 11,331,726 | 4.9% |
| CARVANA CO. | June 06, 2023 | 61,989 | 0.1% |
| EverQuote, Inc. | May 03, 2023 | 1,358,439 | 5.0% |
| CEMEX SAB DE CV | March 03, 2023 | 752,914,110 | 5.0% |
View Baillie Gifford's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-04 |
| SC 13G/A | 2024-04-04 |
| SC 13G/A | 2024-03-07 |
| SC 13G/A | 2024-03-06 |
| SC 13G/A | 2024-02-07 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-02-01 |
| SC 13G/A | 2024-01-30 |
| SC 13G/A | 2024-01-30 |
| SC 13G/A | 2024-01-30 |
View Baillie Gifford's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.